In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer
Article in Pharmaceuticals (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Pharmaceuticals (June 2024)
Article in Chinese Journal of Experimental Surgery (April 2024)
Article in Frontiers in Nuclear Medicine (January 2024)